交易中 04-01 11:53:34 美东时间
+0.130
+0.58%
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
03-26 11:41
BofA Securities has upgraded Acadia Pharmaceuticals (ACAD) to buy from neutral following a recent 25% pullback in share price saying that the company's fundamentals are intact and the downturn was due...
03-25 23:51
B of A Securities analyst Tazeen Ahmad upgrades ACADIA Pharmaceuticals (NASDAQ:ACAD) from Neutral to Buy and maintains the price target from $29 to $29.
03-25 20:46
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:12
“与伊朗开战当然影响我们的钱包,你看油价这些天都涨成什么样了!”美国加利福尼亚州洛杉矶县居民冈萨雷斯17日在阿卡迪亚市的一家加油站对记者抱怨道。记者近日在南加州...
03-18 18:49
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
JP Morgan analyst Tessa Romero maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and raises the price target from $31 to $34.
03-05 04:33
ACADIA Pharmaceuticals Inc. (($ACAD)) has held its Q4 earnings call. Read on fo...
03-02 08:28
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
华盛资讯2月26日讯,阿卡迪亚公布2025财年年度业绩,公司年度营收10.72亿美元,同比增长11.9%,归母净利润3.91亿美元,同比增长72.7%。
02-26 19:36